Title 40 of the Code of Federal Regulations

James P. Herrick Joins Bergeson & Campbell, P.C. and The Acta Group

Retrieved on: 
Monday, June 5, 2023

About Bergeson & Campbell, P.C. -- Located in Washington, D.C., B&C is a law firm focusing on conventional, biobased, and nanoscale industrial, agricultural, and specialty chemical product regulation and approval and associated business issues. Additional information is available at http://www.lawbc.com.

Key Points: 
  • B&C and The Acta Group are pleased to announce that James P. Herrick has joined our firms as a Regulatory Consultant.
  • Mr. Herrick brings nearly two decades of experience at Fortune 500 companies developing, implementing, and managing worldwide environmental, health, and safety (EHS) compliance.
  • (B&C®) and The Acta Group (Acta®) are pleased to announce that James P. Herrick has joined our firms as a Regulatory Consultant.
  • Prior to joining B&C and Acta, Mr. Herrick managed EHS efforts for multinational corporations including Huntsman Corporation and Ashland.

Crave InfoTech launches SAP BTP-powered cMaintenance for Intelligent Asset Management

Retrieved on: 
Wednesday, January 25, 2023

PISCATAWAY, N.J., Jan. 25, 2023 /PRNewswire/ -- Crave InfoTech has launched an all-new SAP Business Technology Platform (BTP) powered product for Intelligent Asset Management – cMaintenance .

Key Points: 
  • PISCATAWAY, N.J., Jan. 25, 2023 /PRNewswire/ -- Crave InfoTech has launched an all-new SAP Business Technology Platform (BTP) powered product for Intelligent Asset Management – cMaintenance .
  • cMaintenance helps maximize the asset lifecycle value with timely scheduled asset inspections, on-floor (RFID or barcode) scanning of assets, parts & instruments, and end-to-end industry-specific Workflows.
  • At the center, the company has industry-veteran engineers leveraging SAP and tech to find ideal solutions for asset maintenance and management issues.
  • Shrikant Nistane, CEO, Crave InfoTech, said, "We have all these insights and knowledge about how the business and industries function.

GSE Solutions Wins Inservice Inspection and Inservice Testing Service Contract

Retrieved on: 
Thursday, September 22, 2022

COLUMBIA, Md., Sept. 22, 2022 /PRNewswire/ -- GSE Systems, Inc. (" GSE Solutions " or "GSE" or the "Company") (Nasdaq: GVP), leader in advanced engineering services and workforce solutions that support the future of clean-energy production and decarbonization initiatives of the power industry, announced today a new $0.5 million contract to provide programmatic services addressing Inservice Inspection (ISI) and Inservice Testing (IST) updates for a nuclear power facility at a US utility.

Key Points: 
  • COLUMBIA, Md., Sept. 22, 2022 /PRNewswire/ -- GSE Systems, Inc. (" GSE Solutions " or "GSE" or the "Company") (Nasdaq: GVP), leader in advanced engineering services and workforce solutions that support the future of clean-energy production and decarbonization initiatives of the power industry, announced today a new $0.5 million contract to provide programmatic services addressing Inservice Inspection (ISI) and Inservice Testing (IST) updates for a nuclear power facility at a US utility.
  • The client, a long-time customer of GSE, has established relationships with GSE experts who have provided support across their engineering organization for years.
  • GSE Solutions leverages top talent and technology to provide advanced engineering services and flexible workforce solutions that support the future of clean energy.
  • GSE is a proven, with over five decades of experience, more than 1,100 installations, and customers in over 50 countries spanning the globe.

ADMA Biologics Announces Record Preliminary Fourth Quarter and Full Year 2021 Revenues and Provides 2022 Business Update

Retrieved on: 
Wednesday, January 19, 2022

RAMSEY, N.J. and BOCA RATON, Fla., Jan. 19, 2022 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics, today announced its preliminary unaudited fourth quarter and full year 2021 revenues. The Company also provided commercial updates for its immune globulin product portfolio as well as 2022 business updates.

Key Points: 
  • The Company also provided commercial updates for its immune globulin product portfolio as well as 2022 business updates.
  • Based on preliminary unaudited financial information, ADMA expects record fourth quarter 2021 revenues of approximately $26 million, compared to $14 million during the fourth quarter of 2020, reflecting an approximately 86% increase.
  • The preliminary results for the fourth quarter of 2021 represent the Companys highest quarterly revenue since its inception.
  • We believe ADMA enters 2022 from a position of strength, and the Company looks forward to continued execution as it enters the next phase of its profit-oriented business cycle.